108 related articles for article (PubMed ID: 27244952)
21. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
Ketha H; Wadams H; Lteif A; Singh RJ
J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
[TBL] [Abstract][Full Text] [Related]
23. The effect of oral loading doses of cholecalciferol on the serum concentration of 25-OH-vitamin-D.
Jansen RB; Svendsen OL
Int J Vitam Nutr Res; 2014; 84(1-2):45-54. PubMed ID: 25835235
[TBL] [Abstract][Full Text] [Related]
24. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC
Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665
[TBL] [Abstract][Full Text] [Related]
26. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
27. Serum 24,25-dihydroxyvitamin D
Graeff-Armas LA; Kaufmann M; Lyden E; Jones G
Clin Nutr; 2018 Jun; 37(3):1041-1045. PubMed ID: 28506446
[TBL] [Abstract][Full Text] [Related]
28. Using new non-invasive quick method to detect Borrelia Burgdorferi (B.B.) infection from specific parts of the heart in "seemingly normal" ECGs, and from the ECGs of Atrial Fibrillation (AF), a majority of AF ECGs are found to have: 1) Significant B.B. infection, 2) Markedly increased ANP, 3) Increased Cardiac Troponin I & 4) Markedly reduced Taurine. These 4 factors were mainly localized at infected areas of the SA node area, R-&L-Atria & pulmonary veins at the L-atrium.
Omura Y; Lu D; Jones MK; Nihrane A; Duvvi H; Yapor D; Shimotsuura Y; Ohki M
Acupunct Electrother Res; 2015; 40(4):297-333. PubMed ID: 26934795
[TBL] [Abstract][Full Text] [Related]
29. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
30. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
Christiansen C; Rødbro P; Christensen MS; Hartnack B; Transbøl I
Lancet; 1978 Sep; 2(8092 Pt 1):700-3. PubMed ID: 80633
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effect of daily versus bolus dose maternal vitamin D
Ketha H; Thacher TD; Oberhelman SS; Fischer PR; Singh RJ; Kumar R
Bone; 2018 May; 110():321-325. PubMed ID: 29486367
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of 1,25-dihydroxyvitamin D3 upon intestinal vitamin D3-dependent calbindin (a 28,000-dalton calcium binding protein) and its mRNA in D-replete and D-deficient chickens.
Hall AK; Reichel H; Norman AW
Arch Biochem Biophys; 1988 Feb; 260(2):645-52. PubMed ID: 2829737
[TBL] [Abstract][Full Text] [Related]
33. Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C.
Omori-Mizuno Y; Nakayama N; Inao M; Funyu J; Asabe S; Tomita K; Nishikawa K; Hosoda Y; Tanaka M; Hashimoto Y; Yakabi K; Koshima Y; Mochida S
J Gastroenterol Hepatol; 2015 Sep; 30(9):1384-90. PubMed ID: 25778685
[TBL] [Abstract][Full Text] [Related]
34. 1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study.
Ferreira GB; Overbergh L; Verstuyf A; Mathieu C
J Steroid Biochem Mol Biol; 2013 Jul; 136():160-5. PubMed ID: 23098690
[TBL] [Abstract][Full Text] [Related]
35. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level.
Vieth R; Chan PC; MacFarlane GD
Am J Clin Nutr; 2001 Feb; 73(2):288-94. PubMed ID: 11157326
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D levels in Swiss breast cancer survivors.
Baumann M; Dani SU; Dietrich D; Hochstrasser A; Klingbiel D; Mark MT; Riesen WF; Ruhstaller T; Templeton AJ; Thürlimann B
Swiss Med Wkly; 2018; 148():w14576. PubMed ID: 29376548
[TBL] [Abstract][Full Text] [Related]
39. Molecular evaluation of vitamin D responsiveness of healthy young adults.
Seuter S; Virtanen JK; Nurmi T; Pihlajamäki J; Mursu J; Voutilainen S; Tuomainen TP; Neme A; Carlberg C
J Steroid Biochem Mol Biol; 2017 Nov; 174():314-321. PubMed ID: 27282116
[TBL] [Abstract][Full Text] [Related]
40. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]